Clinical trials
Terminated Urologic Diseases trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
18 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2002 | 1 |
| 2010 | 2 |
| 2011 | 1 |
| 2015 | 4 |
| 2016 | 1 |
| 2017 | 1 |
| 2020 | 3 |
| 2021 | 1 |
| 2022 | 2 |
| 2023 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 18 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Celldex Therapeutics | 2 |
| Rainier Therapeutics | 2 |
| Spinal Singularity | 2 |
| Avation Medical, Inc. | 1 |
| Bioniche Life Sciences Inc. | 1 |
| Dicerna Pharmaceuticals, Inc., a Novo Nordisk company | 1 |
| Endo USA Inc., a Keenova Therapeutics Company | 1 |
| Goldfinch Bio, Inc. | 1 |
| Johns Hopkins University | 1 |
| Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Urologic Diseases | 18 |
| Neoplasms | 6 |
| Urinary Bladder Diseases | 6 |
| Urinary Bladder Neoplasms | 6 |
| Urologic Neoplasms | 6 |
| Kidney Diseases | 5 |
| Urogenital Neoplasms | 5 |
| Carcinoma, Transitional Cell | 4 |
| Neoplasms by Site | 4 |
| Carcinoma, Renal Cell | 3 |
Trials
Showing 51 to 18 of 18. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.